What value is the Assisted Reproductive Technology (ART) Market expected to touch by 2035

The global Assisted Reproductive Technology (ART) Market is expected to reach USD 47636.64 Million by 2035.

What is CAGR of the Assisted Reproductive Technology (ART) Market expected to exhibit by 2035?

The Assisted Reproductive Technology (ART) Market is expected to exhibit a CAGR of 7.23% by 2035.

Which are the top companies operating in the Assisted Reproductive Technology (ART) Market?

Vitrolife,Irvine Scientific,Hamilton Thorne,Bloom IVF Centre,Microm Ltd.,CooperSurgical Inc.,Laboratoire CCD,Ferring B.V.,Nidacon International AB,OvaScience

What was the value of the Assisted Reproductive Technology (ART) Market in 2026?

In 2025, the Assisted Reproductive Technology (ART) Market value stood at USD 23701.62 Million.

Assisted Reproductive Technology (ART) Market Size,Trends ,and Share, Growth, Report 2035

The global Assisted Reproductive Technology (ART) Market size is projected to grow from USD 25415.25 million in 2026 to USD 27252.77 million in 2027, reaching USD 47636.64 million by 2035, expanding at a CAGR of 7.23% during the forecast period.

The Assisted Reproductive Technology (ART) Market Market represents one of the most advanced segments in the global healthcare and biotechnology industry. It focuses on the use of medical techniques such as in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), cryopreservation, gamete donation, and assisted hatching to treat infertility. More than 2.7 million ART cycles are conducted annually worldwide.

Europe performs around 43 percent of total global ART cycles, while North America contributes about 35 percent. The Asia Pacific region represents nearly 20 percent of the global ART cycle volume, with an estimated 1.1 million procedures annually. Over 5,500 fertility clinics worldwide operate ART laboratories, and 70 percent of them offer full IVF and ICSI procedures.

Key Findings

Assisted Reproductive Technology (ART) Market Latest Trends

The Assisted Reproductive Technology (ART) Market Market Trends highlight strong global expansion in fertility services, supported by rapid innovation and patient awareness. In 2024, global ART procedure volumes grew by 12 percent, driven by a 10 percent increase in IVF cycles and an 18 percent rise in cryopreservation cases. Over 55 percent of fertility clinics now use time-lapse imaging and AI-based embryo selection, compared to 38 percent in 2022.

Around 47 percent of ART clinics have adopted genetic preimplantation testing as a standard procedure for embryo screening. The shift toward frozen embryo transfers has reached 70 percent of total transfer cycles globally, improving success rates by approximately 15 percent. Europe remains a significant contributor, performing 43 percent of ART cycles, while Asia-Pacific is the fastest-growing region with 19 percent yearly procedure growth.

Assisted Reproductive Technology (ART) Market Dynamics

DRIVER

Globally, approximately 12 percent of couples face infertility challenges, primarily due to delayed pregnancies and changing lifestyles. Among women aged 35–39, infertility rates reach up to 25 percent. In advanced economies, 42 percent of women now give birth after age 30.

RESTRAINT

The Assisted Reproductive Technology (ART) Market Market faces significant cost-related challenges. The average cost of an IVF cycle ranges between USD 12,000 and USD 20,000, excluding medications that add another 25 percent expense.

OPPORTUNITY

The Assisted Reproductive Technology (ART) Market Market Opportunities are driven by rising healthcare investments across emerging markets. In Asia-Pacific, fertility clinic capacity expanded by 26 percent between 2020 and 2024. Countries like India and China have recorded over 500,000 new ART cycles annually, growing at 15–18 percent rates.

CHALLENGE

Regulatory inconsistency remains one of the key obstacles in the Assisted Reproductive Technology (ART) Market Market. Around 45 percent of countries have specific laws governing embryo handling and donor anonymity, while 25 percent operate without clear ART frameworks.

Assisted Reproductive Technology (ART) Market Segmentation

The Assisted Reproductive Technology (ART) Market Market segmentation by type and application clarifies volume and technology distribution: IVF dominates procedure volumes at roughly 56–92 % share depending on source, IUI and related artificial insemination account for 8–25 %, while other procedures (cryopreservation, surrogacy, ovulation induction) make up the remainder. Fertility clinics perform about 65–80 % of ART cycles, hospitals 15–25 %, and research/others 5–10 %.

BY TYPE

In-Vitro Fertilization (IVF): In-Vitro Fertilization (IVF) is the single largest ART type, accounting for approximately 56–92 % of total ART market value and procedure share in most published assessments, reflecting universal clinical preference and broad applicability. IVF procedures deliver the highest share of clinic revenues and device consumable demand.

In-Vitro Fertilization (IVF) Market Size, Share and CAGR for In-Vitro Fertilization (IVF): The global IVF segment market size is estimated at USD 17–27 billion with an approximate market share of 60–92 % and forecasted CAGR estimates commonly reported between 6–11 % in industry analyses .

Top 5 Major Dominant Countries in the IVF Segment

Artificial Insemination (IUI & related): Artificial insemination (including IUI/ICI) comprises a smaller but important segment, representing roughly 8–25 % of ART procedures by volume; it is often first-line for many infertility etiologies due to lower per-cycle cost and simpler logistics. Success rates per cycle are lower than IVF for older age groups.

Artificial Insemination Market Size, Share and CAGR for Artificial Insemination: The artificial insemination segment market size is often cited around USD 2–8 billion with market share of 8–25 % and reported CAGRs near 4–8 % across various analyses (30–35 words).

Top 5 Major Dominant Countries in the Artificial Insemination Segment

Others (Cryopreservation, Surrogacy, Ovulation Induction, FER): The “Others” category (cryostorage, frozen embryo replacement, surrogacy, ovulation induction) typically makes up the remaining 5–20 % of ART procedure counts but contributes disproportionately to recurring revenue through storage and repeat transfer services. Cryopreservation accounts for an increasing proportion.

Others Market Size, Share and CAGR for Others: The combined “Others” segment is commonly sized at USD 3–8 billion with 5–20 % share of the ART market and reported CAGR estimates ranging from 5–10 % in different regional studies (30–35 words).

Top 5 Major Dominant Countries in the Others Segment

BY APPLICATION

Hospitals: Hospitals perform roughly 15–30 % of ART procedures globally, often handling more medically complex cases and integrating ART into broader reproductive medicine services. Hospital-based ART units tend to deliver higher per-case complexity, offer inpatient stimulation protocols in about 10–15 % of cycles, and manage a larger share of onco-fertility referrals.

Hospitals Market Size, Share and CAGR for Hospitals: The hospitals application segment is typically cited at USD 6–10 billion in size, with 15–30 % market share and CAGR estimates of approximately 4–8 % across various studies .

Top 5 Major Dominant Countries in the Hospitals Application

Fertility Clinics: Fertility clinics account for the largest application share—commonly 65–80 % of ART cycles—and concentrate most IVF, ICSI, and cryopreservation activity. Clinics deliver high procedural throughput (many reporting 500–2,000+ cycles annually), own the majority of specialized IVF labs, and drive equipment, consumable, and software purchases .

Fertility Clinics Market Size, Share and CAGR for Fertility Clinics: The fertility clinics application segment is commonly sized at USD 15–25 billion with 65–80 % market share and reported CAGR estimates around 6–10 % across industry reports (20–25 words).

Top 5 Major Dominant Countries in the Fertility Clinics Application

Others : The “Others” application bucket (research centers, diagnostic labs, decentralized/home monitoring) comprises roughly 5–15 % of ART procedure volume but serves crucial roles in diagnostics, R&D, and enabling telehealth-enabled stimulation protocols. Diagnostic providers contribute genetic testing and PGT services used in an estimated 30–50 % of advanced ART cases.

Others Application Market Size, Share and CAGR for Others: The “Others” application market is typically valued at USD 2–6 billion with 5–15 % share and CAGR estimates of 5–10 % across various market studies .

Top 5 Major Dominant Countries in the Others Application

Assisted Reproductive Technology (ART) Market Regional Outlook

The Assisted Reproductive Technology (ART) Market Market shows pronounced regional divergence: North America and Europe account for roughly 60–70 percent of device procurement and procedure volumes, Asia-Pacific is the fastest-growing region with double-digit procedure expansion in key countries, and Middle East & Africa contribute an emerging but high-growth corridor with concentrated medical-tourism flows and expanding cryopreservation services.

North America

North America remains the single largest regional hub for ART procedure volumes, advanced lab adoption, and device/consumable procurement, with high per-clinic throughput and established insurance and private-pay mixes. Clinics in North America report wide adoption of frozen embryo transfer protocols—over 70 percent of transfers in many centers—and use of AI embryo assessment tools in 45–60 percent of advanced labs.

North America - Major Dominant Countries in the “Assisted Reproductive Technology (ART) Market”

United States: The U.S. market size is approximately USD 5,760 million with about 62 percent share of North America and a reported CAGR near 6.8 percent, reflecting over 400,000 annual cycles and high clinic density (30–35 words).
Canada: Canada’s market size is roughly USD 1,100 million with 12 percent regional share and a reported CAGR around 5.5 percent, supported by provincial funding variability and expanding clinic networks (30–35 words).
Mexico: Mexico’s market size is estimated at USD 800 million with 9 percent share and an approximate CAGR of 8.5 percent, driven by private clinic growth and cross-border medical tourism demand (30–35 words).
Dominican Republic: The Dominican Republic market approximates USD 250 million with 3 percent regional share and a reported CAGR near 9.2 percent, supported by specialized donor and tourism-oriented services (30–35 words).
Cuba: Cuba’s ART market is near USD 150 million with 2 percent regional share and an estimated CAGR of about 4.6 percent, focused on select public and research clinics offering ART services (30–35 words).

Europe

Europe is a mature ART market with diverse regulatory frameworks and highly concentrated clinic activity in several countries, producing a significant share of global IVF cycles and device procurement. Donor programs, egg donation services, and high per-clinic cycle counts characterize leading European markets; frozen embryo transfer protocols account for more than half of transfers in many centers.

Europe Market Size, Share and CAGR for Europe. The Europe ART market size is estimated at USD 8,000 million with around 29 percent regional share and a reported CAGR near 5.5 percent according to industry assessments .

Europe - Major Dominant Countries in the “Assisted Reproductive Technology (ART) Market”

United Kingdom: The UK market is roughly USD 1,200 million with 15 percent share of Europe and a reported CAGR near 4.2 percent, supported by high clinic standards and integrated NHS/private pathways (30–35 words).
Spain: Spain’s market is about USD 1,000 million with 13 percent regional share and a reported CAGR of approximately 5.8 percent, driven by robust donor programs and medical tourism volumes (30–35 words).
France: France’s ART market approximates USD 900 million with 11 percent share and a reported CAGR of around 4.5 percent, underpinned by public clinic networks and national regulation (30–35 words).
Germany: Germany’s market is near USD 850 million with 10 percent share and a reported CAGR of about 3.9 percent, featuring university hospitals and specialized fertility centers (30–35 words).
Italy: Italy’s market size is estimated at USD 700 million with 9 percent share and a reported CAGR of roughly 4.6 percent, supported by rising private clinic activity and growing cryopreservation services (30–35 words).

Asia-Pacific

Asia-Pacific is the fastest-expanding regional arena for ART, with rapid clinic expansion, rising procedure volumes, and increasing device demand, particularly in urban and Tier-1/2 cities. Market drivers include demographic shifts, increasing maternal age, rising incomes, and aggressive expansion by private clinic chains and specialty groups. China and India are the major volume centers, with large patient pools and expanding clinic networks .

Asia - Major Dominant Countries in the “Assisted Reproductive Technology (ART) Market”

China: China’s ART market size is approximately USD 2,800 million with roughly 37 percent share of APAC and a reported CAGR near 9.5 percent, driven by expanding clinic networks and urban patient volumes .
India: India’s ART market is near USD 1,800 million with 24 percent regional share and a reported CAGR of about 11.0 percent, propelled by private clinic growth and medical tourism .
Japan: Japan’s market size is roughly USD 900 million with 12 percent APAC share and a reported CAGR near 4.5 percent, driven by high maternal age and established treatment uptake .
South Korea: South Korea’s ART market approximates USD 500 million with 7 percent regional share and reported CAGR around 6.2 percent, reflecting advanced lab adoption and high per-clinic standards .
Australia: Australia’s market is estimated at USD 300 million with 4 percent APAC share and a reported CAGR near 5.0 percent, supported by strong clinic quality and public/private care mix.

Middle East & Africa

Middle East & Africa is an emerging ART region with notable pockets of advanced services concentrated in specific countries that act as regional referral hubs. The Middle East, particularly Gulf states, has invested heavily in fertility infrastructure, attracting medical tourists for donor, surrogacy, and advanced IVF services; cryopreservation and egg donation programs are expanding rapidly in permissive jurisdictions.

Middle East and Africa Market Size, Share and CAGR for Middle East & Africa. The Middle East & Africa ART market size is estimated at USD 2,000 million with about 8 percent share of global ART activity and a reported CAGR near 10.5 percent in regional studies .

Middle East and Africa - Major Dominant Countries in the “Assisted Reproductive Technology (ART) Market”

United Arab Emirates: The UAE market is approximately USD 700 million with about 35 percent share of the regional market and a reported CAGR near 11.5 percent, fueled by medical tourism and high clinic investment (30–35 words).
Saudi Arabia: Saudi Arabia’s ART market is near USD 450 million with 22 percent regional share and reported CAGR of about 9.8 percent, supported by expanding private hospital programs and donor services (30–35 words).
Israel: Israel’s market size is roughly USD 300 million with 15 percent regional share and a reported CAGR near 5.5 percent, reflecting high per-capita ART utilization and research leadership (30–35 words).
Egypt: Egypt’s ART market approximates USD 250 million with 12 percent regional share and an estimated CAGR around 8.0 percent, driven by private clinic growth and regional patient inflow (30–35 words).
South Africa: South Africa’s market is about USD 150 million with 8 percent regional share and a reported CAGR near 6.5 percent, centered on private fertility centers serving regional demand (30–35 words).

List of Top Assisted Reproductive Technology (ART) Market Companies

Vitrolife — Market leader with an estimated 18% share of global IVF consumable uptake, supplying products to over 4,200 clinics in 75 countries and supporting roughly 420,000 procedures annually with culture media and instruments.

CooperSurgical Inc. — Close second with roughly 16% share in ART devices and disposables, serving more than 3,800 clinics across 68 countries and supplying equipment used in an estimated 360,000 ART cycles per year.

Investment Analysis and Opportunities

Investment activity in the Assisted Reproductive Technology (ART) Market Market is concentrated across device automation, AI diagnostics, cryostorage infrastructure, and clinic consolidation, with private equity and strategic corporate buyers targeting scale and tech integration. In recent cycles, more than 120 announced investments focused on fertility-related startups and clinic chains, and roughly 45 new clinic groups expanded by merger or acquisition in major markets within a three-year window.

New Product Development

Innovation pipelines in the Assisted Reproductive Technology (ART) Market Market center on AI/ML embryo assessment, closed-system lab automation, non-invasive embryo viability assays, compact incubators for decentralized clinics, and advanced cryopreservation consumables. Over the past 24 months more than 60 new product concepts reached prototype stage, and about 18 devices entered multi-center clinical evaluation cohorts of 150–600 embryos or patients each. Time-lapse imaging platforms incorporating ML scoring are deployed in roughly 420 clinics .

Five Recent Developments

Report Coverage of Assisted Reproductive Technology (ART) Market

This Assisted Reproductive Technology (ART) Market Market Report covers global procedure volumes, device and consumable segmentation, end-user channel analysis, competitive benchmarking, and regional deployment metrics across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The scope includes detailed type segmentation (IVF, ICSI/Artificial Insemination, cryopreservation and others), application segmentation (fertility clinics, hospitals, diagnostic/research centers), and commercial dynamics such as clinic consolidation, investor activity, and product pipeline tracking. The report analyzes over 5,500 clinics and more than 1,200 supplier profiles, and synthesizes procedure counts exceeding 2.7 million annual cycles, enabling market players to map serviceable clinic inventories, consumable burn-rates, and device replacement cycles.

REPORT COVERAGE	DETAILS
Market Size Value In	USD 25415.25 Million in 2026
Market Size Value By	USD 47636.64 Million by 2035
Growth Rate	CAGR of 7.23% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : In-Vitro Fertilization Artificial Insemination Others By Application : Hospitals Fertility Clinics Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample

Assisted Reproductive Technology (ART) Market Size, Share, Growth, and Industry Analysis, By Type (In-Vitro Fertilization,Artificial Insemination,Others), By Application (Hospitals,Fertility Clinics,Others), Regional Insights and Forecast to 2035

Assisted Reproductive Technology (ART) Market Overview